TUTTLINGEN, Germany--(BUSINESS WIRE)--Sep 9, 2025--
STORZ & BICKEL GmbH (“STORZ & BICKEL” or the “Company”), a world-leading manufacturer of high-end, medically certified cannabis vaporizers and a subsidiary of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today unveiled the VEAZY— an accessible new addition to its premium portfolio, extending the Company’s precision engineering to a broader audience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909162411/en/
The VEAZY delivers an uncompromising solution, designed to be as approachable as it is easy to use. The VEAZY is the first vaporizer from STORZ & BICKEL to be available in multiple colors that blend style with function—Charming Pink, Inspiring Orange, Dynamic Blue and Alluring Black.
VEAZY Key Features:
“Consumers have been asking for a vaporizer that combines accessibility with style,” said Jürgen Bickel, Managing Director & Co-Founder, STORZ & BICKEL. “With the VEAZY, we’re expanding the STORZ & BICKEL experience to a new audience while staying true to the superior standards that have defined us for over 25 years.”
The VEAZY is available online at storz-bickel.com and at select licensed retailers worldwide.
To stay up-to-date on the latest product news, follow @storz.bickel on Instagram.
About STORZ & BICKEL GmbH
STORZ & BICKEL GmbH is the global leader in the manufacture of high-end and medically certified cannabis vaporizers. With a commitment to quality, innovation, and compliance, the company has consistently delivered exceptional products that meet the highest industry standards. Based in Tuttlingen, Germany, STORZ & BICKEL continues to drive the advancement of vaporization technology, providing a safe and efficient means of consuming cannabis for medical purposes. For more information, visit www.storz-bickel.com
About Canopy Growth
Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives. Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.
Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA, LLC (“Canopy USA”). Canopy USA’s portfolio includes ownership of Acreage Holdings, Inc., a vertically integrated multi‑state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness, LLC, The Cima Group, LLC, and Mountain High Products, LLC, a leading North American edibles brand, and majority ownership of Lemurian, Inc., a California-based producer of high-quality cannabis extracts and clean vape technology.
At Canopy Growth, we’re shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we’re paving the way for a better understanding of all that cannabis can offer. For more information, visit www.canopygrowth.com.
Introducing The VEAZY: STORZ & BICKEL’s Most Compact and Accessible Vaporizer
NEW HAVEN, Conn.--(BUSINESS WIRE)--May 28, 2026--
Unilever today unveiled plans to develop a new Global Innovation Center in New Haven, Connecticut, opening by spring 2029. The center will be a leading hub for the company’s research and development for its personal care, beauty and wellbeing businesses in the U.S. and globally.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260528022339/en/
The center further propels Unilever’s growth strategy in the U.S. market, raising the bar for research and development in the consumer goods industry and powering the company’s portfolio of innovative and desirable brands. Centrally located in one of the world’s fastest-growing biosciences innovation clusters, the digital-first and AI-powered center will deliver deeper insights to fuel Unilever’s ambition of reshaping product categories. The center will advance how Unilever’s teams of scientists and experts push the boundaries of the fundamental differentiators that make the company’s brands distinct and products desirable: superior science, aesthetics and sensorials.
The center brings together a new and differentiated combination of assets and capabilities that will accelerate breakthroughs and enable Unilever’s brands to bring the next generation of market-making beauty, wellbeing and personal care products to people faster:
The center advances Unilever's strategy to become a sharper, focused personal care, beauty and wellbeing company, built upon shared capabilities across science-led innovation, demand creation and operational execution. Unilever will invest $270 million in the project over the long term, including $50 million in capital expenditure. Total combined investment of public and private funds in the center will exceed $300 million. This investment builds on nearly $15 billion invested in Unilever’s U.S. business over the past decade, across both acquisitions and capital projects.
Approximately 300 employees will work at the center. It will succeed Unilever's existing R&D facility in Trumbull, Connecticut, which has operated since 1972, marking the next chapter of Unilever's long partnership with the State of Connecticut and its scientific community.
Herrish Patel, President of Unilever USA and CEO of Personal Care North America, said:
“New Haven gets us to the future faster. Our Global Innovation Center is where we'll innovate at the intersection of science, technology and culture — for the U.S. and for the world. We will build on our deep heritage of innovation to develop the next generation of brands and products that people love. As part of Unilever’s global network of innovation hubs, the center will connect closely with our other leading locations worldwide, sharing technology, insights, and breakthrough ideas to accelerate innovation at scale. As the U.S. becomes a center of gravity for Unilever, we’re harnessing the best of American innovation to match our growth ambition here in the U.S. and around the world.”
Specific capabilities to be housed at the center include:
Richard Slater, Unilever Chief Research & Development Officer, said:
“Behind every Unilever product is world-leading science that delivers superior performance, combined with design, fragrance and sensory experiences that make our brands distinctive. Our new Global Innovation Center will bring these capabilities together to develop new, category-defining innovations in the U.S., and scale globally. The real shift here is integration and speed: science, design and sensorials working as one, with AI and partnerships accelerating every stage of innovation.”
Connecticut Governor Ned Lamont said:
“Unilever’s decision to make this investment in New Haven reaffirms Connecticut’s global reputation as a leader in innovation, research and development, and discovery. This innovation center will serve as an important foundational piece for this burgeoning hub that will not only strengthen New Haven’s existing tech centers but will also boost our innovation ecosystem statewide. I am glad we have Unilever as a valued member of Connecticut’s growing business community, and I look forward to this company continuing to succeed here for many years to come.”
About Unilever
Unilever is one of the world’s leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, and Foods products, with sales in over 190 countries and products used by 3.7 billion people every day. We have 96,000 employees and generated sales of €50.5 billion in 2025.
Our leading brands in the U.S. include Dove, Hellmann’s, Vaseline, Degree, Axe, TRESemmé, Knorr, Nutrafol, Liquid I.V., Paula’s Choice, and Dermalogica.
For more information on Unilever U.S. and its brands visit: www.unileverusa.com
Rendering of Unilever's future Global Innovation Center in New Haven, opening in spring 2029.
